Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/13/2026 | Q4 | $9.3B | -- | -- | $0.57 | -- |
| 11/07/2025 | Q3 | $8.4B | $10.7B | $0.23 | $0.37 | -$0.14 |
| 08/01/2025 | Q2 | $7.8B | $10.7B | $0.72 | $0.41 | $0.30 |
| 05/09/2025 | Q1 | $7.4B | $12.9B | $0.72 | $0.69 | $0.03 |
| 02/14/2025 | Q4 | $5.4B | $11.8B | $0.16 | $0.52 | -$0.36 |
| 11/01/2024 | Q3 | $4.9B | $10.9B | $0.43 | $0.40 | $0.03 |
| 08/02/2024 | Q2 | $4.2B | $8.3B | $0.63 | $0.46 | $0.17 |
| 05/10/2024 | Q1 | $8.9B | $8.1B | $0.49 | $0.59 | -$0.10 |
| 02/09/2024 | Q4 | $9.9B | $8.3B | $0.60 | $0.49 | $0.10 |
| 11/03/2023 | Q3 | -- | $7.3B | $0.19 | -- | -- |
| 06/30/2023 | Q2 | -- | $7.7B | $0.68 | -- | -- |
| 03/31/2023 | Q1 | -- | $8.4B | $0.63 | -- | -- |
| 12/31/2022 | Q4 | -- | $9.8B | -$0.39 | -- | -- |
| 09/30/2022 | Q3 | -- | $9.2B | $0.48 | -- | -- |
| 06/30/2022 | Q2 | -- | $10.3B | $0.17 | -- | -- |
| 03/31/2022 | Q1 | -- | $11.8B | $0.75 | -- | -- |
| 12/31/2021 | Q4 | -- | $9.8B | $0.72 | -- | -- |
| 09/30/2021 | Q3 | -- | $9.5B | $0.27 | -- | -- |
| 06/30/2021 | Q2 | -- | $8.8B | $0.56 | -- | -- |
| 03/31/2021 | Q1 | -- | $9.3B | $0.74 | -- | -- |
| 12/31/2020 | Q4 | -- | $7.1B | $0.67 | -- | -- |
| 09/30/2020 | Q3 | -- | $6.2B | $0.37 | -- | -- |
| 06/30/2020 | Q2 | -- | $6.3B | $0.59 | -- | -- |
| 03/31/2020 | Q1 | -- | $8.6B | -$0.53 | -- | -- |
| 12/31/2019 | Q4 | -- | $9B | $0.27 | -- | -- |
| 09/30/2019 | Q3 | -- | $8.9B | $0.36 | -- | -- |
| 06/30/2019 | Q2 | -- | $9.7B | $0.64 | -- | -- |
| 03/31/2019 | Q1 | -- | $9.9B | $0.70 | -- | -- |
| 12/31/2018 | Q4 | -- | $8.8B | $0.41 | -- | -- |
| 09/30/2018 | Q3 | -- | $8.6B | -$0.04 | -- | -- |
| 06/30/2018 | Q2 | -- | $8.6B | $0.49 | -- | -- |
| 03/31/2018 | Q1 | -- | $10.2B | $0.21 | -- | -- |
| 12/31/2017 | Q4 | -- | $10.1B | $0.09 | -- | -- |
| 09/30/2017 | Q3 | -- | $7.2B | $0.38 | -- | -- |
| 06/30/2017 | Q2 | -- | $8.1B | $0.42 | -- | -- |
| 03/31/2017 | Q1 | -- | $8.2B | $0.41 | -- | -- |
| 12/31/2016 | Q4 | -- | $7.2B | $0.29 | -- | -- |
| 09/30/2016 | Q3 | -- | $6.6B | -$0.08 | -- | -- |
| 06/30/2016 | Q2 | -- | $6.2B | $0.26 | -- | -- |
| 03/31/2016 | Q1 | -- | $6.2B | $1.00 | -- | -- |
| 12/31/2015 | Q4 | -- | $6.6B | $0.33 | -- | -- |
Enbridge, Inc. reported $10.7B worth of top line sales in its most recent quarter.
Enbridge, Inc. announced earnings per share of $0.23 which represents a miss of analyst forecast a $0.37 per share.
Enbridge, Inc. reported $3.4B that represents $1.55 per share over the last quarter.
Enbridge, Inc.'s earnings are forecast to grow from $1.71 per share to $1.95 per share next year representing an increase of 25.06%.
Enbridge, Inc.'s next earnings date is February 13, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.